Skip to main content
INVAMED
HomeINVAblogAtherectomy or Balloon angioplasty? A Technical Comparison
Peripheral Arterial Disease (PAD)January 16, 2021INVAMED Medical Affairs

Atherectomy or Balloon angioplasty? A Technical Comparison

Atherectomy vs Balloon angioplasty: a balanced, educational comparison of how each works, their trade-offs, and how INVAMED supports both — not medical…

This article compares two approaches side by side to clarify how they differ in principle and practice. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.

Background: Peripheral Arterial Disease (PAD)

Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs.

Atherectomy vs Balloon angioplasty: Key Differences

Balloon angioplasty widens an artery by compressing and stretching plaque, while atherectomy removes or modifies plaque tissue. In heavily calcified lesions, atherectomy can improve vessel compliance so that subsequent ballooning is more effective. Atherectomy adds procedural steps and often embolic protection; angioplasty is simpler but may struggle with hard calcium. The two are frequently combined, and the strategy is chosen by the operator.

How INVAMED Supports Both Approaches

Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.

Key Considerations

  • INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
  • Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting.
  • Access sheath sizing should match the planned devices to limit access-site complications.

Frequently Asked Questions

Who decides which PAD device to use?

A vascular specialist selects devices based on lesion characteristics; this content is educational and not a treatment recommendation.

What atherectomy device does INVAMED make?

INVAMED's TemREN system is positioned for peripheral atherectomy and plaque modification, often used with the Guardian embolic protection device.

Is a stent always needed in PAD?

No. Many lesions are treated with angioplasty or drug-coated balloons alone; a stent is added when the vessel recoils or dissects.

Clinical and Technical Context

Atherectomy is often paired with embolic protection to capture dislodged debris. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes. Appropriate access selection helps reduce access-site complications. Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting. Use is guided by lesion morphology and clinician preference. INVAMED's Guardian protection device is designed for this distal-capture role. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. Embolic protection is often paired with atherectomy to capture dislodged debris. Manufacturer figures reflect studied device performance, not guaranteed outcomes. Covered stent grafts can be used to exclude certain lesions or manage complications. Access sheath sizing should match the planned devices to limit access-site complications. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels.

Related on INVAMED

Important Disclaimer

This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.

Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.

Reviewed by: INVAMED Medical Affairs

This content is prepared for educational purposes for healthcare professionals and does not constitute medical advice. Always consult clinical guidelines and product instructions for use.

Atherectomy vs Balloon angioplastyperipheral artery disease treatmentPTA balloon catheter (percutaneous transluminal angioplasty)atherectomy procedurerecovery timesuccess raterestenosis rate